In accordance with the Food and Drug Safety Administration's change order for pharmaceutical manufacturing (import) product approval (Drug Management Division-No. 7934, effective date 2008.07.21), the precautions for use of Roxlin tablets have been changed.
 


For further details, please refer to the ‘Product Introduction’ section and attached documents.